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Abstract
Background: Decision aids have been developed in a number of health disciplines to support evidence-informed
decision making, including patient decision aids and clinical practice guidelines. However, policy contexts differ
from clinical contexts in terms of complexity and uncertainty, requiring different approaches for identifying,
interpreting, and applying many different types of evidence to support decisions. With few studies in the literature
offering decision guidance specifically to health policymakers, the present study aims to facilitate the structured
and systematic incorporation of research evidence and, where there is currently very little guidance, values and
other non-research-based evidence, into the policy making process. The resulting decision aid is intended to help
public sector health policy decision makers who are tasked with making evidence-informed decisions on behalf of
populations. The intent is not to develop a decision aid that will yield uniform recommendations across
jurisdictions, but rather to facilitate more transparent policy decisions that reflect a balanced consideration of all
relevant factors.
Methods/design: The study comprises three phases: a modified meta-narrative review, the use of focus groups,
and the application of a Delphi method. The modified meta-narrative review will inform the initial development of
the decision aid by identifying as many policy decision factors as possible and other features of methodological
guidance deemed to be desirable in the literatures of all relevant disciplines. The first of two focus groups will then
seek to marry these findings with focus group members’ own experience and expertise in public sector
population-based health policy making and screening decisions. The second focus group will examine issues
surrounding the application of the decision aid and act as a sounding board for initial feedback and refinement of
the draft decision aid. Finally, the Delphi method will be used to further inform and refine the decision aid with a
larger audience of potential end-users.
Discussion: The product of this research will be a working version of a decision aid to support policy makers in
population-based health policy decisions. The decision aid will address the need for more structured and
systematic ways of incorporating various evidentiary sources where applicable.
Background
Advances in healthcare and social policy have led to
dramatic improvements in health worldwide. However,
health systems remain under severe pressure. Prevalent
trends among high-income countries, including decreas-
ing economic growth rates, escalating costs, aging popu-
lations, and elevated public expectations, feed concerns
about sustainability, cost-containment, quality improve-
ment, and accountability [1]. In response to these
pressures, governments and health organizations are
increasingly relying on evidence of effectiveness, appro-
priateness and implementability to justify practices and
policies. The World Health Organization (WHO) has
added further emphasis, highlighting the need to
develop mechanisms to support the use of research evi-
dence in creating clinical practice guidelines, health
technology assessments, and health policy [2]. Underly-
ing this trend is the positioning of scientific rigour as a
means of enhancing the legitimacy and effectiveness of
decision-making processes.
Decision aids/support tools (hereafter referred to as
decision aids) have been developed in a number of
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sion-making. One example is the extensive development
of clinical practice guidelines used to influence clinical
decision-making (e.g., http://www.guidelines.gov). A
recent systematic review in the Netherlands found that
evidence-based clinical guidelines helped to improve
processes and structures of care and patient health out-
comes [3]. Another example relates to patient decision
aids, increasingly used as an effective way to improve
patients’ understanding of treatment options and to
incorporate this information into ‘shared’ clinician-
patient decision-making processes. O’Connor et al.
demonstrated that patient decision aids for those facing
decisions concerning cancer screening and treatment
have a positive effect in improving patients’ understand-
ing of the determinants of decisions (i.e., better knowl-
edge of options, benefits, or risks; more realistic
expectations; value-based) [4].
In contrast to the clinical context, decision aids to
support health policy processes and structures are less
well developed. Policy contexts have different complex-
ities and uncertainties than clinical contexts that require
different approaches for identifying, interpreting, and
applying various types of evidence to support decisions
[5-9]. A recent series of articles edited by Oxman and
Hanney contributed to filling this gap within health pol-
icy decision making, developing a series of tools to sup-
port various aspects of health policy making related to
research evidence, from the identification of research
evidence needs and the search for and assessment of
such evidence to its translation into policy decisions
[10]. The tools also brought to light some policy consid-
erations other than research evidence (e.g.,v a l u e s ,w i n -
dows of opportunity, the use of policy dialogues);
however, they do not directly provide an explicit
approach for assessing and incorporating this non-
research evidence into the decision-making process.
While this work is comprehensive in its approach to the
integration of research evidence, particularly systematic
reviews, into policy decisions, the focus remains on
research evidence rather than adequately representing
all types of evidence in the policy decision.
The proposed study aims to add to the current state
of knowledge by focusing on how to support health
policy decision making more generally, not only in
relation to using research evidence but also to the
structured and systematic incorporation of non-
research evidence into the policy-making process.
Non-research evidence, or colloquial evidence, can be
understood as the expertise, views, and realities of sta-
keholders, including ‘evidence about resources, expert
and professional opinion, political judgment, values,
habits and traditions, lobbyists and pressure groups,
and the particular pragmatics and contingencies of the
situation’ [11]. This proposed study is part of an over-
arching project that is examining how evidence from
various sources, research-based and otherwise, is incor-
porated into colorectal cancer (CRC) screening policy
decisions in five Canadian provincial health systems.
Previously conducted key informant interviews with
clinical leaders, screening experts, regional/local
administrative leaders, and government officials from
these five provinces helped to evaluate and compare
the policy-making processes (including evidence utili-
zation therein) used in their decisions to (not) imple-
ment population-based CRC screening programs.
Given a common research evidence-base to inform the
provinces’ policy decisions, inter-provincial variation
was apparent in both policy decision processes and
outcomes. The current study seeks to build upon those
interview findings in order develop a decision aid to
inform a decision to implement a population-based
cancer screening program. The decision aid is meant
to assist policy makers in thinking through different
elements of these complex decisions by providing a
comprehensive series of prompts that elicit both
research- and non-research-based evidence pertinent
to the policy decision. The intent is not to develop a
decision aid that will yield uniform recommendations
across jurisdictions; however, the decision aid should
facilitate more transparent policy decisions that incor-
porate broader and more appropriate types of evi-
dence. The aid will be targeted for use by policy
makers and those supporting them. The former
include those with the power to make or influence pol-
icy decisions; the latter include those who facilitate by
informing those decisions [12]. Recognizing these dif-
ferent roles, the decision aid is not intended for use by
any single individual but is meant for the collaborative
and interdependent efforts that comprise the policy-
making process. While an appropriate governing
authority ideally should take responsibility for using
the decision aid, it is expectedt h a tv a r i o u si n d i v i d u a l s
and groups with different skills and expertise will be
tasked with assessing and contributing the relevant
information as highlighted by the decision aid’sk e y
components.
Based on the above considerations, this study will
address, both descriptively and normatively, the follow-
ing research questions:
1. What is (should be) the purpose of a decision aid
for population-based health policy decisions?
2. How are (should) decision aids for population-based
health policy decisions (be) conceptualized and
constructed?
3. How are (should) decision aids for population-based
health policy decisions (be) operationalized and
implemented?
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The development of the proposed decision aid will be
guided by three methods: modified meta-narrative
review, focus groups, and the Delphi method.
Phase one: modified meta-narrative review
A modified meta-narrative review will be used to inform
the initial development of the decision aid. Findings of
the review will help to identify current and possible
domains to be considered in a policy decision aid and
various other construction aspects (e.g., information pre-
sentation, format of decision aid, et al.). Because
research on decision aids spans many fields and disci-
plines and uses diverse terms and definitions, standard
systematic reviews are not an ideal approach for review-
ing the literature [13]. In contrast, the meta-narrative
review method, developed by Greenhalgh et al. [14], is
better for sorting through a vast, heterogeneous litera-
ture encompassing multiple research fields carried out
by different scientific communities. Its use of narrative
and acknowledgement of different contributing research
traditions enables a comprehensive comparison of the
literature(s) despite differences in methodology, jargon,
criteria for success and quality assessment, and
approaches to research questions.
The development of the meta-narrative review method
stemmed from a large literature review of the diffusion
of innovations [15]. As part of this approach, a large
multidisciplinary research team, whose backgrounds
spanned the relevant research traditions of interest, was
assembled. This was done by seeking collaborations
between different institutions and departments in order
to provide the appropriate skill mix. In comparison, our
proposed meta-narrative review will be led by a single
investigator in consultation with five to ten advisors
assembled to provide expertise in a range of different
fields for guiding the review. The number of advisors
will depend on the number of relevant research tradi-
tions identified. As noted by Greenhalgh et al. [14], the
list of key research traditions relevant to the research
questions will likely evolve as data emerge through the
review process.
An initial exploratory search will be conducted to
identify potential research traditions relevant to decision
aids and respective experts in related fields (e.g.,e v i -
dence-based medicine, patient decision aids, shared
decision making, knowledge translation/exchange, policy
frameworks/tools, et al.). This search will be carried out
through review of traditional healthcare and non-health-
care indexes (e.g., Medline, Embase, Scholar’sP o r t a l ,et
al.), Google searches and consultations with experts in
the field. Potential advisors will be formally contacted
and invited to participate.
Following the exploratory search, expert advisors will
be interviewed individually at two time points. The
initial interview will be conducted prior to beginning
the formal literature search. The purpose of this inter-
view will be to have expert advisors provide guidance on
relevant tradition-specific areas of research (e.g., specific
search terms, relevant databases, predominant theoreti-
cal bases, et al.), and identify seminal articles and pro-
minent concepts or themes to support the search and
mapping phases of the review. The investigator will then
identify and map articles within each research tradition
by searching electronic databases, reviewing reference
lists of identified papers, contacting key authors in each
tradition, and searching the grey literature. The search
will focus on work that explores the development of a
decision aid rather than only the use of an aid. Compar-
able studies will be grouped together along with key
findings. The mapping phase will result in a narrative
account tracing the historical development of concepts,
theory, and methods within each research tradition,
referred to as meta-narratives.
In synthesizing the research findings across traditions,
key themes or dimensions pertinent to our research ques-
tion will be identified, along with the contribution(s) of
each meta-narrative to it. Divergence between meta-narra-
tives with respect to these themes will be examined for
possible theoretical causes arising from the meta-narra-
tives in question. It is at this point that expert advisors will
be interviewed a final time, presenting them with working
narrative accounts to ensure accurate and thorough inter-
pretation of the literature within each tradition. In con-
cluding the meta-narrative review, overall findings will be
summarized and a series of recommendations will be
made for its practical application to the development of a
decision aid to support evidence-informed public sector
population-based health policy decisions. As highlighted
by Greenhalgh et al. [14], recommendations should be
grounded through the context provided by multidisciplin-
ary dialogue and consultation with potential end-users of
the review. In this case, the context will be the current pol-
icy environment wherein public sector health policy deci-
sions are made on behalf of the population. Thus, the
meta-narrative review overlaps and feeds into the next
phase of the proposed study, focus groups. Initial findings
from the meta-narrative review will be used to create a
guide for the first focus group discussion enabling mem-
bers to reflect and comment on the meta-narrative review
findings, given their experiences and expertise regarding
high-level health policy making.
Phase two: focus groups
Two focus groups will be conducted with approximately
10 to 12 members of Canada’sN a t i o n a lC o l o r e c t a l
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as a national forum for review, discussion, and action on
matters of mutual interest or concern related to CRC
screening [16]. Network membership comprises key
decision makers (including clinicians and political lea-
ders at provincial and territorial levels) and cancer con-
trol community partners across Canada. A presentation
of this study has been delivered to members of the
NCCSN during their May 2010 meeting, where indivi-
dual members expressed interest in participating. Mem-
bers will receive a formal email invitation to participate
in the focus group. The invitation will provide further
study details, outlining the purpose, methods, and
expected findings/deliverables of the research study,
expectations for their involvement in the study, potential
risks associated with study participation, and the mea-
sures that will be taken to ensure the confidentiality of
responses.
The objective of the first focus group will be to elicit
the expertise and experience of focus group members in
public sector population-based health policy making and
screening decisions. This will provide context for
grounding the recommendations made from the modi-
fied meta-narrative review. Discussions will revolve
around construction aspects (e.g., information domains,
information representation, format of decision aid, et
al.). Moreover, they will provide guidance as to how
these recommendations – in conjunction with overall
findings from the meta-narrative review and key infor-
mant interviews from earlier work – can be applied in
the development of the decision aid within the current
policy environment. As a working draft of the decision
aid is developed based on findings from the previously
conducted key informant interviews, the modified meta-
narrative review, and the first focus group session, it will
be sent to participants in advance of conducting the sec-
ond focus group. The objective of the second focus
group will then be to examine issues of application (e.g.,
feasibility, usefulness, et al.) and inform further refine-
ments to the draft decision aid which will be the focus
of the Delphi method.
Phase three: delphi method
The Delphi method facilitates consensus among a panel
of experts through a series of structured questionnaires,
known as rounds [17]. We chose this technique as it
offers a systematic and interactive approach to eliciting
expert and stakeholder opinions (particularly targeting
end-users of the decision aid). Further, it provides the
advantage of consulting with a larger, geographically
diverse and interdisciplinary group than other methods,
like the nominal group technique would allow [18]. The
objective of this phase of our study is to further inform
and refine the decision aid, following changes made
according to the focus group feedback.
Because the literature has not established consensus
on the appropriate sample size for expert panels [19-21],
the main goal was to assemble a purposive sample,
representative of major stakeholders within the CRC
screening decision-making process. All key informants
interviewed as part of the completed stages of the
broader study examining evidence utilization in support
of CRC screening policy in the five provinces (n = 56)
and members of the NCCSN (n = 35) will be invited to
participate on the Delphi panel (n = 78 after excluding
duplicates). We anticipate that approximately 50 invitees
will participate in the panel, based on the interest
received at the NCCSN meeting held in May 2010 and
the enthusiasm of key informants during previous inter-
views. Prospective panellists will receive a formal invita-
tion to participate in the Delphi panel. The invitation
will outline the purpose, methods, and expected find-
ings/deliverables of the research study, expectations for
their involvement in the study, potential risks associated
with study participation, and measures that will be
taken to ensure the confidentiality of responses. A sur-
vey will be created to elicit panellists’ expert opinions
and experience as to the feasibility, usefulness, and com-
prehensiveness of the various elements contained within
the draft decision aid. In addition, a qualitative compo-
nent will be included as part of the survey to allow par-
ticipants the opportunity to discuss and compare the
proposed decision aid with current practices and its fit
within current policy processes. The survey will be dis-
tributed to members of the Delphi panel through a web-
based survey tool. After each round, the Delphi panel
will be presented with an anonymous summary of the
previous round’s results, along with noteworthy com-
ments and rationale for judgements from which they fill
out the next round of survey. The process will carry on
until either consensus among panellists is reached or a
point of saturation is achieved where no novel data are
collected [22].
Discussion
In answering our research questions looking at the pur-
pose, development, and operationalization of a decision
aid to support population-based health policy decisions,
a working version of a decision aid will be produced
and will have received preliminary evaluation through
the focus groups and Delphi. While the context of our
study lies within cancer screening policy decisions, it is
our hope that the decision aid will be generalizable to
other health policy decisions, which we will target in
subsequent research. The decision aid aims to facilitate
decision makers in making transparent decisions and
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ways of integrating various evidentiary sources where
applicable. We believe the study design is appropriate to
achieve these aims. The modified meta-narrative review
will provide invaluable insights in the creation of the
decision aid, particularly because population-based
health policy decisions are often made in the context of
significant complexity and uncertainty, drawing from a
broad array of evidentiary sources and impacting various
different policy sectors. Conducting the focus groups
and Delphi technique are important steps in developing
and refining the decision aid to ensure its appropriate-
ness and implementability in the current policy
environment.
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